Palvella Therapeutics Inc (PVLA)
$146.15 -3.58% Close Oct 30, 2026 Live
Palvella Therapeutics stock today
Palvella Therapeutics closed at $146.15 on October 30, 2026, down 3.58% on the day. Over the past year it returned +86.4% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $2.10 billion.
$75.00$100.00$125.00$150.00
NovJan 2026MarMayJulSep
| Period | PVLA | S&P 500 (SPY) |
|---|---|---|
| 1 month | +6.0% | -0.9% |
| 3 months | -2.7% | +2.1% |
| Year to date | +39.6% | +11.7% |
| 1 year | +86.4% | +12.4% |
Key statistics
- Market value
- $2.10B
- 52-week range
- $75.06 to $158.13
- Next report
- Nov 5, 2026
About Palvella Therapeutics
Develops therapeutics for cancer and other diseases using proprietary technology platforms.
Sector: Health Care
More on Palvella Therapeutics
- Financials: revenue, earnings and segmentsRevenue -18% in the year to Dec 2022
- Returns: what $1,000 became$1,000 one year ago is $1,864 today
No forecast, no recommendation. This page describes Palvella Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.